Pages that link to "Item:Q2437016"

The following pages link to Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin (Q2437016):

Displaying 21 items.

• Towards prediction of HCV therapy efficiency (Q612807) (← links)
• vRNA structured population model for Hepatitis C virus dynamics (Q738183) (← links)
• Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (Q739328) (← links)
• Hopf bifurcation and stability switches induced by humoral immune delay in hepatitis C (Q828950) (← links)
• Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis (Q907619) (← links)
• Evaluating treatment of hepatitis C for hemolytic anemia management (Q975959) (← links)
• Global analysis of a mathematical model for hepatitis C considering the host immune system (Q1706549) (← links)
• Influence of intracellular delay on the dynamics of Hepatitis C virus (Q1794656) (← links)
• Analysis of hepatitis C viral dynamics using Latin hypercube sampling (Q1948250) (← links)
• Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection (Q1989670) (← links)
• The influence of vaccination on the control of JE with a standard incidence rate of mosquitoes, pigs and humans (Q2053100) (← links)
• Machine learning for mathematical models of HCV kinetics during antiviral therapy (Q2118485) (← links)
• Stochastic analysis of in-host HCV dynamics through budding and bursting process (Q2205386) (← links)
• Threshold dynamics of HCV model with cell-to-cell transmission and a non-cytolytic cure in the presence of humoral immunity (Q2207871) (← links)
• Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy (Q2219723) (← links)
• Modeling the effect of non-cytolytic immune response on viral infection dynamics in the presence of humoral immunity (Q2296898) (← links)
• Dynamical analysis of a class of hepatitis C virus infection models with application of optimal control (Q2799329) (← links)
• Dynamics of an HBV Model with Drug Resistance Under Intermittent Antiviral Therapy (Q2944477) (← links)
• Modeling of Viral Dynamics after Liver Transplantation in Patients with Chronic Hepatitis B and D (Q5738254) (← links)
• Some sufficient conditions for global asymptotic stability of a hepatitis C virus mathematical model considering host immune system (Q6142136) (← links)
• Observer‐based controller for treatment of hepatitis C infection using fractional order model (Q6189714) (← links)